T. Andrew Clayton

Pharmaco-metabonomic phenotyping and personalized drug treatment

T. Andrew Clayton, John C. Lindon, Olivier Cloarec et al. · Nature · 2006 · 827 citations

Medicine, Molecular Medicine, Pharmacology +14

Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism

T. Andrew Clayton, David Baker, John C. Lindon et al. · Proceedings of the National Academy of Sciences · 2009 · 764 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

An Integrated Metabonomic Approach To Describe Temporal Metabolic Disregulation Induced in the Rat by the Model Hepatotoxin Allyl Formate

Ivan Kok Seng Yap, T. Andrew Clayton, Huiru Tang et al. · Journal of Proteome Research · 2006 · 90 citations

Pharmacy, Biochemistry, Toxicology +17

Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism

T. Andrew Clayton · FEBS Letters · 2012 · 82 citations · Full text

Life Sciences, Biochemistry, Microbiology +17

Chiral Configurations of Cyclophosphazenes

D.B. Davies, T. Andrew Clayton, Robert E. Eaton et al. · Journal of the American Chemical Society · 2000 · 72 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13